TYP 0.00% 2.0¢ tryptamine therapeutics limited

Ann: Preclinical Data from Osteoarthritis Animal Study, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 385 Posts.
    lightbulb Created with Sketch. 167
    Early Rat study, doesn't mean much really, dont really get the weak selling.

    What I want to know is WHERE ARE THE PHASE 2 PLEX trial results, They are due !!!!

    "PLEXOVAL II Clinical Trial Activities Complete Dosing of the 11 participants in PLEXOVAL II has completed and final follow-up medical appointments with all test subjects are also completed. No adverse events related to the treatment using Plexaris or the placebo were reported. The data will now be analysed by an independent third party with final results expected by around March 2021. “
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.000(0.00%)
Mkt cap ! $21.78M
Open High Low Value Volume
2.0¢ 2.0¢ 2.0¢ $5.8K 290K

Buyers (Bids)

No. Vol. Price($)
3 400039 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 280953 1
View Market Depth
Last trade - 15.22pm 10/10/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.